Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants (NCT07673900)
A Randomized, Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Epi/Intra-dermally Administered Semaglutide (VX-201) Compared to Subcutaneous Administration in Healthy Overweight and Obese Participants: Single and Multiple Dose Assessment
🩺 Plain-English Summary (8th-Grade Level)
VX-201-101 is a first-in-human Phase 1 clinical study evaluating VX-201, a needle-free microneedle (MN) array patch (MAP) that delivers semaglutide through the skin as an alternative to subcutaneous (SC) injection.
Who can join: Review the eligibility criteria below.
Location: Celerion Clinical Research — Tempe, Arizona
Age range: 18 Years to 60 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Celerion Clinical Research — Tempe, Arizona
📞 Contact the Study Coordinator
Phone: (339) 330-0088
Email: lynda@terrestrialbio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overweight and/or Obesity
- Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program — Chapel Hill, North Carolina
- Optimization of Dietary Adherence in a Mobile Weight Loss Intervention — Chapel Hill, North Carolina
- Brief Inhibitory Training for Eating - Intervention — Fairfax, Virginia
- Family-Based Nutrition Intervention to Prevent Overweight and Obesity in School-Age Children. — México, Sonora
Explore by condition: All Overweight and/or Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.